350 results on '"Fulp, William J."'
Search Results
2. Diagnostic Resolution of Cancer Screening Abnormalities at Community Health Centers
3. Surgeon Bias in the Management of Positive Sentinel Lymph Nodes
4. Is it Wise to Omit Sentinel Node Biopsy in Elderly Patients with Breast Cancer?
5. Intrinsic radiosensitivity, genomic-based radiation dose and patterns of failure of penile cancer in response to adjuvant radiation therapy
6. Oral gargle-tumor biopsy human papillomavirus (HPV) agreement and associated factors among oropharyngeal squamous cell carcinoma (OPSCC) cases
7. A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study
8. A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responses
9. Supplementary Table S1 from Plasma MicroRNAs as Novel Biomarkers for Patients with Intraductal Papillary Mucinous Neoplasms of the Pancreas
10. Data from Plasma MicroRNAs as Novel Biomarkers for Patients with Intraductal Papillary Mucinous Neoplasms of the Pancreas
11. Supplementary Figure S3 from Plasma MicroRNAs as Novel Biomarkers for Patients with Intraductal Papillary Mucinous Neoplasms of the Pancreas
12. Supplementary Figure Legends from Plasma MicroRNAs as Novel Biomarkers for Patients with Intraductal Papillary Mucinous Neoplasms of the Pancreas
13. Data from BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival
14. Supplementary Tables 1 - 2 from Validation of a Radiosensitivity Molecular Signature in Breast Cancer
15. Supplementary Figure 1 from BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival
16. Supplementary Table 2 from BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival
17. Supplementary Methods from BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival
18. Data from Racial Differences in the Incidence and Clearance of Human Papilloma Virus (HPV): The HPV in Men (HIM) Study
19. Supplementary Data from Combination of Farnesyltransferase and Akt Inhibitors Is Synergistic in Breast Cancer Cells and Causes Significant Breast Tumor Regression in ErbB2 Transgenic Mice
20. Supplementary Table 1 from Racial Differences in the Incidence and Clearance of Human Papilloma Virus (HPV): The HPV in Men (HIM) Study
21. Supplementary Table 1 from BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival
22. Supplementary Table 3 from BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival
23. Integration of a Radiosensitivity Molecular Signature Into the Assessment of Local Recurrence Risk in Breast Cancer
24. Differences Between Colon Cancer Primaries and Metastases Using a Molecular Assay for Tumor Radiation Sensitivity Suggest Implications for Potential Oligometastatic SBRT Patient Selection
25. Human immunoglobulin gene allelic variation impacts germline-targeting vaccine priming
26. Human Papillomavirus Virus (HPV) Genotype- and Age-Specific Analyses of External Genital Lesions Among Men in the HPV Infection in Men (HIM) Study
27. Vaccination induces HIV broadly neutralizing antibody precursors in humans
28. Florida Initiative for Quality Cancer Care: Improvements in Breast Cancer Quality Indicators During a 3-Year Interval
29. Senescence-associated-gene signature identifies genes linked to age, prognosis, and progression of human gliomas
30. The Role of Monogamy and Duration of Heterosexual Relationships in Human Papillomavirus Transmission
31. 'Secure' Log-Linear and Logistic Regression Analysis of Distributed Databases
32. Outcomes of a Clinical Pathway for Borderline Resectable Pancreatic Cancer
33. Early and Long-Term HIV-1 Immunogenicity Induced in Macaques by the Combined Administration of DNA, NYVAC and Env Protein-Based Vaccine Candidates: The AUP512 Study
34. Telomere length and risk of melanoma, squamous cell carcinoma, and basal cell carcinoma
35. TP53 suppression promotes erythropoiesis in del(5q) MDS, suggesting a targeted therapeutic strategy in lenalidomide-resistant patients
36. Country‐specific HPV‐related genital disease among men residing in Brazil, Mexico and The United States: The HIM study
37. Phase I study of combination of pasireotide LAR + gemcitabine in locally advanced or metastatic pancreatic cancer
38. Analysis of Incidental Radiation Dose to Uninvolved Mediastinal/Supraclavicular Lymph Nodes in Patients with Limited-Stage Small Cell Lung Cancer Treated Without Elective Nodal Irradiation
39. Expression of the Antiapoptotic Protein Survivin in Colon Cancer
40. Secure, Privacy-Preserving Analysis of Distributed Databases
41. Single-Institution Retrospective Comparison of Preoperative Versus Definitive Chemoradiotherapy for Adenocarcinoma of the Esophagus
42. The impact of pathologic nodal status on survival following neoadjuvant chemoradiation for locally advanced rectal cancer
43. STAT3 polymorphisms may predict an unfavorable response to first-line platinum-based therapy for women with advanced serous epithelial ovarian cancer
44. Genomic identification of sarcoma radiosensitivity and the clinical implications for radiation dose personalization
45. Outcomes of Therasphere Radioembolization for Colorectal Metastases
46. Lung tumor NF-κB signaling promotes T cell--mediated immune surveillance
47. Cutaneous Angiosarcoma: A Single-Institution Experience
48. Phase II clinical study of erlotinib for treatment of myelodysplastic syndromes
49. A prospective analysis of smoking and human papillomavirus infection among men in the HPV in Men Study
50. Adjuvant Radiotherapy and Lymph Node Dissection in Pancreatic Cancer Treated With Surgery and Chemotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.